BindingDB logo
myBDB logout

13 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
23206862 22 Identification of a novel benzimidazole derivative as a highly potent NPY Y5 receptor antagonist with an anti-obesity profile.EBI Shionogi
23025998 20 Identification of a novel and orally available benzimidazole derivative as an NPY Y5 receptor antagonist with in vivo efficacy.EBI Shionogi
22853998 164 Design, synthesis and identification of novel benzimidazole derivatives as highly potent NPY Y5 receptor antagonists with attractive in vitro ADME profiles.EBI Shionogi
22300657 29 Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist.EBI Shionogi
19596193 72 Design, synthesis and evaluation of a novel cyclohexanamine class of neuropeptide Y Y1 receptor antagonists.EBI Tsukuba Research Institute
19464889 43 Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists.EBI Tsukuba Research Institute
15951170 12 Isomeric thiazole derivatives as ligands for the neuropeptide Y5 receptor.EBI F. Hoffmann-La Roche
15745805 13 Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry design.EBI F. Hoffmann-La Roche
30399314 532 Design of YEBI TBA
20030505 6 Stereoselective inhibition of butyrylcholinesterase by enantiomers of exo- and endo-2-norbornyl-N-n-butylcarbamates.BDB Chung Shan Medical University Hospital